3VHA

Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor

3VHA の概要

• エントリーDOI: 10.2210/pdb3vha/pdb
• 関連するPDBエントリー: 3B24 3B25 3B26 3B27 3B28 3VHC 3VHD
• 分子名称: Heat shock protein HSP 90-alpha, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, 22-methyl-13,18-dioxa-7-thia-3,5-diazatetracyclo[17.3.1.1~2,6~.1~8,12~]pentacosa-1(23),2(25),3,5,8(24),9,11,19,21-nonaen-4-amine, ... (4 entities in total)
• 機能のキーワード: chaperone-chaperone inhibitor complex, chaperone/chaperone inhibitor
• 由来する生物種: Homo sapiens (human)
• 細胞内の位置: Cytoplasm: P07900
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 26362.68

構造登録者

Fukami, T.A.,Ono, N. (登録日: 2011-08-24, 公開日: 2012-07-18, 最終更新日: 2024-03-20)

主引用文献

Suda, A.,Koyano, H.,Hayase, T.,Hada, K.,Kawasaki, K.,Komiyama, S.,Hasegawa, K.,Fukami, T.A.,Sato, S.,Miura, T.,Ono, N.,Yamazaki, T.,Saitoh, R.,Shimma, N.,Shiratori, Y.,Tsukuda, T.
Design and synthesis of novel macrocyclic 2-amino-6-arylpyrimidine Hsp90 inhibitors
Bioorg.Med.Chem.Lett., 22:1136-1141, 2012

PubMed Abstract: Macrocyclic compounds bearing a 2-amino-6-arylpyrimidine moiety were identified as potent heat shock protein 90 (Hsp90) inhibitors by modification of 2-amino-6-aryltriazine derivative (CH5015765). We employed a macrocyclic structure as a skeleton of new inhibitors to mimic the geldanamycin-Hsp90 interactions. Among the identified inhibitors, CH5164840 showed high binding affinity for N-terminal Hsp90α (K(d)=0.52nM) and strong anti-proliferative activity against human cancer cell lines (HCT116 IC(50)=0.15μM, NCI-N87 IC(50)=0.066μM). CH5164840 displayed high oral bioavailability in mice (F=70.8%) and potent antitumor efficacy in a HCT116 human colorectal cancer xenograft model (tumor growth inhibition=83%).

PubMed: 22192591
DOI: 10.1016/j.bmcl.2011.11.100

実験手法

X-RAY DIFFRACTION (1.39 Å)